Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients
Clinical trial NCT03194321 · COMPLETED
Trial details
- NCT number
- NCT03194321
- Sponsor
- Cedars-Sinai Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2020-10-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.